Annual report pursuant to Section 13 and 15(d)

Supplemental Balance Sheet Information (Tables)

v3.24.1
Supplemental Balance Sheet Information (Tables)
12 Months Ended
Dec. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of accrued expenses and other current liabilitiies

Accrued expenses and other current liabilities consist of the following:

 

 

 

December 31,
2023

 

 

December 31,
2022

 

Accrued consulting

 

$

49,395

 

 

$

232,390

 

Accrued compensation

 

 

635,451

 

 

 

459,997

 

Accrued research and development

 

 

1,472,292

 

 

 

1,696,129

 

Accrued other

 

 

102,817

 

 

 

9,920

 

Total accrued expenses and other current liabilities

 

$

2,259,955

 

 

$

2,398,436